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Introduction
Symptoms like syncope or palpitations are common conditions 
in clinical practice, thus having a significant impact on the patient’s 
quality of life. They are frequent causes of cardiology referral and 
even hospitalization.1 Due to the variety of underlying possible 
mechanisms, the precise diagnosis relies on the correlation between 
symptoms and electrocardiography evidence at the time of episodes. 
However, given the paroxysmal and unpredictable nature of these 
symptoms, they frequently present a diagnostic challenge.
The choice of monitoring technique in different clinical situations 
should be driven by the stratification risk and predicted rate of 
symptom recurrence.1,2 Conventional Holter monitoring and external 
loop recorders are known to have low diagnostic yield, and even after 
an extensive evaluation many patients remain undiagnosed.3,4 A 
long-term monitoring through an implantable loop recorder (ILR) 
is an important aid in the management of these patients.
In recent years, significant advances have been made in diagnosing 
and understanding the mechanisms of rhythm conditions, with an 
increased number of patients having a final diagnosis. This increment 
has been greatly enhanced by the development and widespread 
use of the ILR. It is a small subcutaneous device for continuous 
electrocardiographic monitoring that can be extremely useful in 
the diagnosis of syncope of undetermined origin after the initial 
assessment, in patients with unrecorded palpitations that occur 
occasionally, in detection of atrial fibrillation and study of cryptogenic 
stroke.5 The efficacy and safety of the ILR as a diagnostic tool has 
already been demonstrated in several studies.6,7,8
The aim of this study was to describe the experience of a tertiary 
center with the use of ILR.
Material and Methods
A retrospective, observational, single-center study of consecutive 
patients that underwent ILR implantation during a seven years 
period. All patients had a Cardiology evaluation and at least a basic 
study with an ECG and transthoracic echocardiogram previous to 
the procedure.
We collected clinical and electrocardiographic data from a 
prospective database and from medical electronic and ILR records.
We used the Reveal DX/XT/LINQ ILR device (Medtronic) 
a subcutaneously implantable device for long-term continuously 
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cardiac rhythm monitoring for up to three years. The device was 
subcutaneously implanted in the left parasternal region, under local 
anesthesia. Events could be recorded by two methods: manually 
activated by the patients in case of symptoms or automatically 
triggered when arrhythmic events satisfied the pre-programmed 
cut-off criteria for asystole, brady or taquiarrhythmias and atria 
or ventricular fibrillation. Generally, the device memory can 
automatically store between 27 to 29 automatically activated events 
with 30 seconds of pre-activation and 27 seconds of post-activation 
and 3 patient-activated events with 6.5 minutes of pre-activation and 
1 minute of post-activation, with few variances according to the type 
of arrhythmic event and program design. Patients had a first follow-
up visit in three months, in six months intervals thereafter, and 
after every event activated. Sixteen patients had CareLink remote 
monitoring system that transmits the information of the arrhythmic 
event or activated episodes at distance to a web server that can be 
accessed by the assistant doctor or arrhythmic unit staff.
In the present study, the implantation indication, baseline 
characteristics, study previous to ILR implantation, complications 
of procedure, recorded monitoring tracings and subsequent 
interventions, were evaluated for each patient
The statistical analysis was performed with SPSS 20 version.
Results 
Between November 2007 and November 2014 a total of 62 
patients were included, 50% were men, with a mean age of 62.5±18.8 
years old. The demographic and clinical characteristics of patients are 
presented in Table 1. All patients had a baseline echocardiogram and 
ECG, with 95% of the patients in sinus rhythm. QRS complex and 
atrial ventricular conduction was normal in 63.1% of the patients. 
17.3% presented with first degree atrioventricular block, 12.9% had 
right bundle branch block and 6.7% left bundle branch block. Further 
ECG characteristics are described in Table 2. In 19.4% structural 
heart disease was identified and 88.7% of the patients had a normal 
left ventricular ejection fraction.
Previously to ILR implantation, 88.7% of the patients had 
performed at least one Holter monitoring, 17.7% an external event 
recorder, 33.9% a Tilt table test and 29% an electrophysiological 
study. Thus, 23.3% of patients underwent more than two different 
types of complementary exams before IRL implantation without a 
clear diagnosis.
Regarding the implantation indications, 90.3% were for recurrent 
syncope/presyncope, 8.1% for palpitations complaints and in one 
case, ischemic stroke with suspected cardioembolic origin after initial 
assessment. Mean follow-up time was 17.1±16.3 months (IQR 
4-30). During follow-up, symptoms were reported in 66.1% (n=41) 
of the patients and from those, 29 (46.8%) yielded a diagnostic 
finding ( 44.5% of the patients with syncope, 60% of patients with 
palpitations symptoms and in the ischemic stroke case), with a mean 
time of 12.8 ± 14.4 months (IQR 1.5-21.5) from device implantation 
to diagnosis. In all cases of palpitations symptoms with diagnosis AF 
with ventricular rapid response was found.For patients with syncope, 
atrioventricular conduction disturbance was demonstrated in 19.6%, 
sinus node dysfunction in 16.1%, paroxysmal supra-ventricular 
tachycardia in 7.1% and AF with slow ventricular rate in 1.8%. In the 
ischemic stroke case AF was detected after 5 months of monitoring 
(Table 3). There were no significant differences in the baseline ECG 
characteristics (rhythm disorders, intra-ventricular or atrioventricular 
conduction disturbance) or findings in the previous study, when 
compared to the group in which no diagnosis was obtained.
Subsequently to the diagnosis obtained by the ILR, the following 
therapeutic interventions were pursuit: 19 patients received a 
permanent pacemaker, one a cardiac resynchronization therapy 
device, in five patients anticoagulation was introduced, and one was 
submitted to ablation of an accessory pathway.
There were no major complications reported during the 
implantation procedure or follow-up time. The mortality rate was 
4.8% (n = 3) all from non-cardiac causes.
Discussion
The objective of this study was to describe our center’s experience 
with the use of ILR and establish its safety and efficacy in real world 
practice. 
Current guidelines for the management of patients with 
syncope,2 palpitations9 and AF10 recommend the use of prolonged 
electrocardiogram monitoring techniques to better establish a 
correlation between the symptoms and a specific ECG finding, so 
as to achieve a precise diagnosis.  Its indication was also expanded 
to different clinical scenarios like the study of cryptogenic stroke or 
after myocardial infarction.3,11,12 However, the 2014 European Heart 
Rhythm Association survey, which assessed the use of different 
monitoring techniques in the evaluation of patients with these 
clinical situations (unexplained syncope, palpitations and diagnosis 
Table 2:
Electrocardiography characteristics. AV: atrioventricular; RBBB: 
right bundle branch block; LAFB: Left anterior fascicular block; 
LBBB: left bundle branch block
ECG baseline characteristics
Sinus Rhythm 95.2%
Atrial Fibrillation 4.8%
Normal QRS and AV conduction 63.1%
First degree AV block 12.5%
RBBB 4.9%
RBBB+ LAFB 8.0%
LAFB 1.6%
LAFB + First degree AV block 3.2%
LBBB 5.1%
LBBB + First degree AV block 1.6%
Table 1:
Patient demographic and clinical characteristics. * Left ventricular 
function quantification according to Recommendations for 
Cardiac Chamber Quantification by Echocardiography in Adults: 
An Update from American Society of Echocardiography and the 
European Association of Cardiovascular Imaging. Journal of the 
American Society of Echocardiography. January 2015
Baseline characteristics
Age (years old) 62.5 ± 18.8
Male gender 50.0 %
Hypertension 64.5%
Dyslipidemia 37.1%
Diabetes 16.1%
Ischemic heart disease 9.7%
Left ventricular function *
Normal 88.7%
Mildly abnormal 3.2%
Moderately abnormal 6.5%
Severely abnormal 1.6%
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AF) in different European centers, found discrepancies and poor 
adherence to the guidelines regarding the use of IRL, specially in the 
management of patients with unexplained syncope, in which only a 
minority of non high-risk patients seemed to receive an IRL as part 
of  theirs diagnostic practice.1
In our study, the main indication for ILR use was recurrent 
syncope/pre syncope (90.3%) and only a minority implanted ILR 
for palpitations complaints or in stroke investigation. This data 
demonstrate that clinicians are still reluctant to use ILR in situations 
like unexplained palpitations, cryptogenic stroke or AF. Moreover, 
in our study, IRL was only used after a previous extensive evaluation 
with several non-invasive and even invasive techniques, with 23.3% 
of the patients being submitted to more than two different types 
of complementary exams without a clear diagnosis before IRL 
implantation was considered. This approach is indubitably associated 
to higher costs and resources consumption, with longer period 
of time from symptoms to diagnosis. In the PICTURE registry 
that enrolled 570 patients, the median number of tests performed 
per patient was 13, being ECG, transthoracic echocardiogram, 
ambulatory ECG monitoring, in hospital ECG monitoring, exercise 
tests and orthostatic blood pressure measurement the tests most 
frequently performed.8 The reason for this late referral to ILR 
implantation, shown in several studies and confirmed in our study, 
is unknown, especially after ILR had proven to be able to provide an 
earlier diagnosis of the underlying rhythm disturbance, along with a 
reduction in the number of advanced cardiac tests performed.8 Recent 
studies showed that ILR monitoring is likely to be a cost effective 
strategy especially in patients who present infrequent symptoms 
suspected to be arrhythmic.13
In our study the diagnostic yield of the ILR was 46.8% over a period 
of 12.8 ± 14.4 months and provided useful information in another 
19.3% in which arrhythmic events were excluded as symptoms cause. 
These results are in accordance with other published data describing 
similar diagnostic rates.6,7,8 Several randomized studies that compared 
the use of prolonged ILR monitoring to conventional tests in the 
study of unexplained syncope, demonstrated the efficacy and safety of 
the ILR as a diagnostic tool. The study of Krahn et al that included 60 
consecutive patients with unexplained syncope randomized to IRL 
monitoring or conventional investigation, described a diagnostic yield 
of 52% vs 20% (p=0.012).7 The FRESH study presented a diagnostic 
rate of 46.2% with IRL monitoring for patients with unexplained 
syncope and the study of Farwell DJ. et al, a single center study that 
evaluated the diagnosis yield of IRL compared with conventional 
strategy showed that an ECG diagnosis was identified in 33% of 
ILR group in contrast with only 4% in the other patients.14,15 Similar 
efficacy rates were also described for patients with palpitations. The 
RUP study, that included 50 patients with unexplained palpitation, 
compared the diagnostic rate and the costs of ILR implantation 
with the use of conventional strategy (24 hours Holter recording, 
a 4-week period of ambulatory ECG monitoring with an external 
recorder, and electrophysiological study). This study demonstrated 
the superiority of the IRL approach with a diagnosis rate of 73% vs 
21% in conventional group (p<0.001) and costs of 3.056 ±363 euro 
vs 6.768±6.672 euro (p= 0.012).16
The majority of our patients with episodes of syncope of arrhythmic 
origin had bradyarrhythmic events, with atrioventricular conduction 
disturbances or sinus node dysfunction as main causes.  This data was 
in accordance with diagnostic findings in ISSUE study.2,17 
An interesting feature in our study was that all patients with 
palpitations complains in which a diagnosis was achieved had 
paroxysmal episodes of AF as cause of their symptoms. This is 
possibly explained by the paroxysmal nature of this arrhythmia, 
frequently presented by short but symptomatic episodes, most of 
which very difficult to diagnose with other monitoring methods. In 
RUP study the main diagnostic findings for palpitations symptoms 
were supraventricular tachycardia and AF/atrial flutter both in 6 of a 
total of 19 patients with a final arrhythmic diagnose.16  Several data 
showed that AF detection increases with monitoring intensification. 
However the use of ILR in AF setting has some limitations especially 
related to their limited storage capacity and problems on the detection 
channel, with either undersensing or oversensing that can triggering 
storage of ECG data that have no clinical significance.18,19
The AF detection algorithm operates through an assessment on 
the regularity of RR intervals within a 2 minutes time window. It 
requires at least 2 minutes of AF for the device to recognize the 
rhythm as AF and automatically store the episode. Shorter episodes 
can only be captured manually activated by patients. Once AF is 
diagnosed, it is stored as a sustained AF episode within the automatic 
episode counter, showing date and time of occurrence as well as 
episode length. However, when storage is exhausted, older EGMs 
are overwritten with newer ones and only the final events are kept 
in the memory as EGM. Considering these limited storage capacity, 
the diagnostic accuracy of ILR may be lower in patients with a high 
number of false positive episodes.20,21
The initial study of Hindricks G. et al that access the performance 
of the ILR with a dedicated AF detection algorithm found a high 
sensitivity of 96.1% for AF detection and a high negative predictive 
value, while specificity was limited by falsely stored AF episodes in 
15% of the patients.20 Also in the study of Eitel C. et al, interrogations 
with automatically stored AF episodes containing only EGMs with 
sinus rhythm and artefacts leading to AF misdetection could be 
found in 22% in the group with conventional AF detection algorithm. 
The reasons found for AF misdetection were the occurrence of 
myopotentials/noise in 35%, T-wave oversensing in 1.5%, frequent 
premature ventricular or atrial complexes in 15% and R-wave 
undersensing in 4%.21
In order to supplant these limitations specific AF detection 
algorithms with a software upgrade have been developed. The 
mentioned upgraded software aims a reduction of noise induced 
false-positive AF episodes by reducing the noise rejection threshold 
from 60 to 5 seconds.  Furthermore the patient can check whether 
EGM storage capacity is exhausted.21
The previous referred study of Eitel C.et al, had as main objective 
to analyse the performance of the implantable continuous AF 
detection device in a clinical setting before and after introduction of 
a software upgrade. The results demonstrated that the introduction of 
Table 3: Diagnostic findings according to ILR implantation reasons
ILR implantation reason Diagnostic finding
Syncope (90.3%)
Atrioventricular conduction disturbance 19.6%
Sinus node dysfunction 16.1%
Paroxysmal supra-ventricular tachycardia 7.1%
Atrial fibrillation 1.8%
Palpitations (8,1%) Atrial fibrillation 100%
Ischemic stroke (1.6%) Atrial fibrillation 100%
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the new software significantly reduced the number of patients with 
a misdetection of AF (72% vs 44% p=0.001), mainly attributable to 
a significantly reduction of false AF detection due to myopotentials 
or noise. The number of patients with clinically non-diagnostic 
interrogations was also reduced from 38% to 16%.21
Additional to software developments, several other measures and 
follow-up strategies were proposed to increase the ILR accuracy: the 
need of confirmation on manual EGM analysis of all automatically 
detected episodes; prevention of EGM storage overcrowding with 
remote monitoring techniques, individual device programming and 
follow-up schedules or the presence of an alarm signal indicating 
full storage thus leading to a visit to the device clinic. Other possible 
measure could be prolongation of the detection period for sustained 
AF in order to prevent episodes of misdetection, but shorter AF 
episodes will then be unrecognized. However additional data are 
needed to assess the impact of these measures on ILR diagnostic 
accuracy in the clinical setting.18,19,21
Regarding the use of ILR on detection or in confirmation of 
absence of AF during long-term follow-up, especially after AF 
ablation procedures, ILR is also able to measure AF burden. In our 
study AF burden is not described, as data beyond the first detection 
of AF was not collected for study purpose. However, recent studies 
of pacemaker data have shown that morbidity is dependent on the 
burden of AF, supporting the value of its measurement.22
In our study, the baseline ECG characteristics or findings from 
previous exams were not predictive of diagnostic achievement in 
IRL. Predictive factors for ILR diagnosis have not been adequately 
investigated.  In a recent study of Ahmed N et al. the authors studied 
predictors for pacemaker implantation in the IRL population with 
unexplained syncope. From a total of 200 patients with ILR for 
unexplained syncope, a pacemaker was implanted in 33 patients 
due to significant bradycardia. The predictive factors for occurrence 
of bradycardia necessitating pacemaker were predominantly clinical 
characteristics as history of injury secondary to syncope and female 
sex, with or without ECG conduction abnormalities.23
In the present study, no major adverse complications or events 
were reported during the implantation or follow-up period thus 
confirming the safety of this method.
The main limitations of our study were inherent to its design. It 
was a retrospective, observational, single-center study involving a 
small number of patients.
Conclusions
In our experience, the ILR proved to be a safe and useful 
complementary diagnostic method, with a significant additional 
efficacy compared to other routine electrocardiographic monitoring 
methods. In our study, ILR has enabled the identification or exclusion 
of serious rhythm disturbances in more than half of patients and 
provided a targeted therapeutic intervention. These results are in 
accordance with published data and emphasize the early use of IRL 
in the investigation of symptoms with suspected arrhythmic basis.
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